Differential expression of toll-like receptor mRNAs in recurrent aphthous ulceration

Journal of Oral Pathology and Medicine

Volumn 41, Issue 1, 2012, Pages 80-85

  Gallo, Camila ^a   Barros, Fabiana ^b   Sugaya, Norberto ^a   Nunes, Fabio ^a   Borra, Ricardo ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO LEOPOLDO MANDIC INSTITUTE AND RESEARCH CENTER   (Brazil)

Author keywords

Aphthous ulcerations; Oral mucosa; Wound healing

Indexed keywords

MESSENGER RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ADULT; APHTHOUS ULCER; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; DISEASE SUSCEPTIBILITY; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMATITIS, APHTHOUS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 5; TOLL-LIKE RECEPTORS; YOUNG ADULT;

EID: 84855459666     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2011.01047.x     Document Type: Article

References (45)

1. Ship JA, Chavez EM, Doerr PA, et al. Recurrent aphthous stomatitis. Quintessence Int 2000; 31: 95-112.
2. Scully C, Porter S. Oral mucosal disease: recurrent aphthous stomatitis. Br J Oral Maxillofac Surg 2008; 46: 198-206.
3. Bonifati C, Ameglio F. Cytokines in psoriasis. Int J Dermatol 1999; 38: 241-51.
4. Frassanito MA, Dammacco R, Cafforio P, et al. Th1 polarization of the immune response in Behcet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum 1999; 42: 1967-74.
5. Ehrenstein MR, Evans JG, Singh A, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 2004; 200: 277-85.
6. Van Deventer SJ. Tumour necrosis factor and Crohn's disease. Gut 1997; 40: 443-8.
7. Buno IJ, Huff JC, Weston WL, et al. Elevated levels of interferon gamma, tumor necrosis factor alpha, interleukins 2, 4, and 5, but not interleukin 10, are present in recurrent aphthous stomatitis. Arch Dermatol 1998; 134: 827-31.
8. Lewkowicz N, Lewkowicz P, Banasik M, et al. Predominance of Type 1 cytokines and decreased number of CD4(+)CD25(+high) T regulatory cells in peripheral blood of patients with recurrent aphthous ulcerations. Immunol Lett 2005; 99: 57-62.
9. Jacobi A, Debus D, Schuler G, et al. Infliximab in a patient with refractory mucosal aphthosis. J Eur Acad Dermatol Venereol 2008; 22: 109-10.
10. Robinson ND, Guitart J. Recalcitrant, recurrent aphthous stomatitis treated with etanercept. Arch Dermatol 2003; 139: 1259-62.
11. Sanchez-Cano D, Callejas-Rubio JL, Ruiz-Villaverde R, et al. Recalcitrant, recurrent aphthous stomatitis successfully treated with adalimumab. J Eur Acad Dermatol Venereol 2009; 23: 206.
12. Cario E. Barrier-protective function of intestinal epithelial Toll-like receptor 2. Mucosal Immunol 2008; 1(Suppl 1): S62-6.
13. Qi H, Denning TL, Soong L. Differential induction of interleukin-10 and interleukin-12 in dendritic cells by microbial toll-like receptor activators and skewing of T-cell cytokine profiles. Infect Immun 2003; 71: 3337-42.
14. Re F, Strominger JL. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J Immunol 2004; 173: 7548-55.
15. Dillon S, Agrawal A, Van Dyke T, et al. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol 2004; 172: 4733-43.
16. Novak N, Haberstok J, Bieber T, et al. The immune privilege of the oral mucosa. Trends Mol Med 2008; 14: 191-8.
17. Sutmuller RP, den Brok MH, Kramer M, et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Investig 2006; 116: 485-94.
18. Liu H, Komai-Koma M, Xu D, et al. Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. Proc Natl Acad Sci USA 2006; 103: 7048-53.
19. Lewkowicz N, Lewkowicz P, Dzitko K, et al. Dysfunction of CD4(+)CD25(high) T regulatory cells in patients with recurrent aphthous stomatitis. J Oral Pathol Med 2008; 37: 454-61.
20. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 2004; 127: 224-38.
21. Chen J, Rao JN, Zou T, et al. Polyamines are required for expression of Toll-like receptor 2 modulating intestinal epithelial barrier integrity. Am J Physiol 2007; 293: G568-76.
22. Borra RC, de Mesquita Barros F, de Andrade Lotufo M, et al. Toll-like receptor activity in recurrent aphthous ulceration. J Oral Pathol Med 2009; 38: 289-98.
23. An H, Qian C, Cao X. Regulation of Toll-like receptor signaling in the innate immunity. Sci China Life Sci 2010; 53: 34-43.
24. Liew FY, Xu D, Brint EK, et al. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev 2005; 5: 446-58.
25. Mahanonda R, Sa-Ard-Iam N, Eksomtramate M, et al. Cigarette smoke extract modulates human beta-defensin-2 and interleukin-8 expression in human gingival epithelial cells. J Periodontal Res 2009; 44: 557-64.
26. Kadowaki N, Ho S, Antonenko S, et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001; 194: 863-9.
27. Muzio M, Bosisio D, Polentarutti N, et al. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 2000; 164: 5998-6004.
28. Merlo A, Calcaterra C, Menard S, et al. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses. J Leukoc Biol 2007; 82: 509-18.
29. Zeng H, Wu H, Sloane V, et al. Flagellin/TLR5 responses in epithelia reveal intertwined activation of inflammatory and apoptotic pathways. Am J Physiol 2006; 290: G96-108.
30. Crellin NK, Garcia RV, Hadisfar O, et al. Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J Immunol 2005; 175: 8051-9.
31. Vijay-Kumar M, Sanders CJ, Taylor RT, et al. Deletion of TLR5 results in spontaneous colitis in mice. J Clin Investig 2007; 117: 3909-21.
32. Lun SW, Wong CK, Ko FW, et al. Expression and functional analysis of toll-like receptors of peripheral blood cells in asthmatic patients: implication for immunopathological mechanism in asthma. J Clin Immunol 2009; 29: 330-42.
33. Depaolo RW, Tang F, Kim I, et al. Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis. Cell Host Microbe 2008; 4: 350-61.
34. Pierik M, Joossens S, Van Steen K, et al. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis 2006; 12: 1-8.
35. Stanislawowski M, Wierzbicki PM, Golab A, et al. Decreased Toll-like receptor-5 (TLR-5) expression in the mucosa of ulcerative colitis patients. J Physiol Pharmacol 2009; 60(Suppl 4): 71-5.
36. Albanidou-Farmaki E, Giannoulis L, Markopoulos A, et al. Outcome following treatment for Helicobacter pylori in patients with recurrent aphthous stomatitis. Oral Dis 2005; 11: 22-6.
37. Elsheikh MN, Mahfouz ME. Prevalence of Helicobacter pylori DNA in recurrent aphthous ulcerations in mucosa-associated lymphoid tissues of the pharynx. Arch Otolaryngol Head Neck Surg 2005; 131: 804-8.
38. Maleki Z, Sayyari AA, Alavi K, et al. A study of the relationship between Helicobacter pylori and recurrent aphthous stomatitis using a urea breath test. J Contemp Dent Pract 2009; 10: 9-16.
39. Karaca S, Seyhan M, Senol M, et al. The effect of gastric Helicobacter pylori eradication on recurrent aphthous stomatitis. Int J Dermatol 2008; 47: 615-7.
40. Cavassani KA, Ishii M, Wen H, et al. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med 2008; 205: 2609-21.
41. Kariko K, Ni H, Capodici J, et al. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 2004; 279: 12542-50.
42. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000; 68: 7010-7.
43. Durand SH, Flacher V, Romeas A, et al. Lipoteichoic acid increases TLR and functional chemokine expression while reducing dentin formation in in vitro differentiated human odontoblasts. J Immunol 2006; 176: 2880-7.
44. Dolganiuc A, Garcia C, Kodys K, et al. Distinct Toll-like receptor expression in monocytes and T cells in chronic HCV infection. World J Gastroenterol 2006; 12: 1198-204.
45. Campos MS, Rodini CO, Pinto-Junior DS, et al. GAPD and tubulin are suitable internal controls for qPCR analysis of oral squamous cell carcinoma cell lines. Oral Oncol 2009; 45: 121-6.